がんの処置のための骨髄由来抑制細胞機能の免疫調節

Japanese Patent JP2023538590

A

本開示は、各々が生体材料調製物及び骨髄由来抑制細胞機能のモジュレーター（例えば、好中球機能のモジュレーター）を含む組成物ならびにがん処置のためのその使用に関する技術を提供する。【選択図】なし

JP2022544934	Extracellular vesicles containing STAT3-antisense oligonucleotides
JPH07509470	[Title of Invention] A method of using a fatty acid synthesis inhibitor for the treatment of cancer.
JP2003506097	Description of the Invention: A composition and a method for increasing cholesterol outflow and increasing HDL using the ATP-binding cassette transporter protein ABC1.

goldberg, michael solomon

JP2023512048A

September 08, 2023

August 17, 2021

Click for automatic bibliography generation  

SURGE Therapeutics, Inc.

A61K45/00; A61K31/155; A61K31/202; A61K31/395; A61K31/407; A61K31/41; A61K31/437; A61K31/4439; A61K31/454; A61K31/506; A61K31/519; A61K31/53; A61K38/05; A61K38/55; A61K39/395; A61K47/34; A61K47/36; A61P35/00; A61P35/04; A61P43/00

Norito Yamao
Norifumi Tomita
Fumio Inai
Manami Sasakura
Yusuke Shirae

Previous Patent: Unmanned aerial vehicles with resistance to hijacking, jamming, and spoofing attacks

Next Patent: Compositions for treating gastrointestinal adenocarcinoma by altering the tumor microenvironment